{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:19Z","timestamp":1793608039049,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2026BBF02003"],"award-info":[{"award-number":["2026BBF02003"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007540","name":"Jiangsu Provincial Agricultural Science and Technology Innovation Fund","doi-asserted-by":"publisher","award":["CX(24)1010"],"award-info":[{"award-number":["CX(24)1010"]}],"id":[{"id":"10.13039\/100007540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129121","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:40:00Z","timestamp":1788522000000},"page":"129121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus"],"prefix":"10.1016","volume":"92","author":[{"given":"Yiqing","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2026.129121_bb0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1637\/aviandiseases-D-21-00106","article-title":"Infectious bronchitis virus types affecting European countries-a review","volume":"65","author":"de Wit","year":"2021","journal-title":"Avian Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129121_bb0010","first-page":"1326","article-title":"Status and challenges for vaccination against avian H9N2 influenza virus in China","volume":"12","author":"Dong","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-025-01115-y","article-title":"Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens","volume":"10","author":"Hu","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129121_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1325346","article-title":"Avian infectious bronchitis virus (AIBV) review by continent","volume":"14","author":"Rafique","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129121_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.104256","article-title":"Molecular characteristic, evolution, and pathogenicity analysis of avian infectious bronchitis virus isolates associated with QX type in China","volume":"103","author":"Lu","year":"2024","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2026.129121_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rvsc.2017.06.024","article-title":"Experimental co-infection of infectious bronchitis and low pathogenic avian influenza H9N2 viruses in commercial broiler chickens","volume":"115","author":"Hassan","year":"2017","journal-title":"Res Vet Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129121_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02107-20","article-title":"Gammacoronavirus avian infectious bronchitis virus and alphacoronavirus porcine epidemic diarrhea virus exploit a cell-survival strategy via upregulation of cFOS to promote viral replication","volume":"95","author":"Yuan","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1099\/0022-1317-68-1-57","article-title":"Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus","volume":"68","author":"Boursnell","year":"1987","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129121_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.103939","article-title":"Molecular epidemiology of infectious bronchitis virus in eastern and southern China during 2021-2023","volume":"103","author":"Meng","year":"2024","journal-title":"Poult Sci"},{"issue":"7874","key":"10.1016\/j.vaccine.2026.129121_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.vaccine.2026.129121_bb0055","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1016\/j.vaccine.2021.08.081","article-title":"SARS-COV-2 recombinant receptor-binding-domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1","volume":"39","author":"Law","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129121_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2225645","article-title":"Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses","volume":"12","author":"Fereidouni","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"30","key":"10.1016\/j.vaccine.2026.129121_bb0070","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.vaccine.2006.10.051","article-title":"An overview of the epidemiology of avian influenza","volume":"25","author":"Alexander","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13238-014-0111-7","article-title":"H9N2 influenza virus in China: a cause of concern","volume":"6","author":"Sun","year":"2015","journal-title":"Protein Cell"},{"issue":"7814","key":"10.1016\/j.vaccine.2026.129121_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41586-020-2333-6","article-title":"Structural transitions in influenza haemagglutinin at membrane fusion pH","volume":"583","author":"Benton","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0085","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/s41467-024-49487-4","article-title":"Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin","volume":"15","author":"Lei","year":"2024","journal-title":"Nat Commun"},{"issue":"745","key":"10.1016\/j.vaccine.2026.129121_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj4685","article-title":"Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease","volume":"16","author":"Luo","year":"2024","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129121_bb0095","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.chom.2024.06.015","article-title":"Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin","volume":"32","author":"Welsh","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"7896","key":"10.1016\/j.vaccine.2026.129121_bb0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","article-title":"Broadly neutralizing antibodies target a haemagglutinin anchor epitope","volume":"602","author":"Guthmiller","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"issue":"37","key":"10.1016\/j.vaccine.2026.129121_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci Adv"},{"issue":"24","key":"10.1016\/j.vaccine.2026.129121_bb0115","doi-asserted-by":"crossref","first-page":"25045","DOI":"10.1021\/acsnano.3c07669","article-title":"Development of self-assembled protein nanocage spatially functionalized with HA stalk as a broadly cross-reactive influenza vaccine platform","volume":"17","author":"Park","year":"2023","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.vaccine.2026.129121_bb0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314905120","article-title":"Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgammaR-dependent protection in vivo","volume":"120","author":"Edgar","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129121_bb0125","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/vaccines12121448","article-title":"Combination adjuvants enhance recombinant H5 hemagglutinin vaccine protection against high-dose viral challenge in chickens","volume":"12","author":"He","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129121_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/v14102115","article-title":"DNA prime and recombinant protein boost vaccination confers chickens with enhanced protection against chicken infectious anemia virus","volume":"14","author":"Liu","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2287682","article-title":"A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage","volume":"13","author":"Kong","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.129121_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1144924","article-title":"Global emergence of infectious bronchitis virus variants: evolution, immunity, and vaccination challenges","volume":"2023","author":"Abozeid","year":"2023","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2498574","article-title":"Epidemiology and evolutionary dynamics of H9N2 avian influenza virus in Bangladesh","volume":"14","author":"Islam","year":"2025","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veae106","article-title":"Origin, spread, and interspecies transmission of a dominant genotype of BJ\/94 lineage H9N2 avian influenza viruses with increased threat","volume":"10","author":"Zhou","year":"2024","journal-title":"Virus Evol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129121_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2025.105564","article-title":"Evolution and transmission dynamics of infectious bronchitis virus in southern China during 2018-2023: emergence of a novel GI-19 subtype and re-emergence of GI-28","volume":"104","author":"Xie","year":"2025","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2026.129121_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2024.110163","article-title":"Co-infection of H9N2 subtype avian influenza virus and QX genotype live attenuated infectious bronchitis virus increase the pathogenicity in SPF chickens","volume":"295","author":"Huang","year":"2024","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2026.129121_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vetmic.2017.02.015","article-title":"Co-infection of H9N2 subtype avian influenza virus and infectious bronchitis virus decreases SP-A expression level in chickens","volume":"203","author":"Huang","year":"2017","journal-title":"Vet Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129121_bb0170","article-title":"Vaccination of poultry against highly pathogenic avian influenza - part 1. Available vaccines and vaccination strategies","volume":"21","author":"Health, E. P. o. A","year":"2023","journal-title":"EFSA J"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129121_bb0175","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.5455\/OVJ.2025.v15.i7.40","article-title":"Protective efficacy of commercially available infectious bronchitis vaccination regimes against heterologous IBV QX challenge","volume":"15","author":"Elfeil","year":"2025","journal-title":"Open Vet J"},{"key":"10.1016\/j.vaccine.2026.129121_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2024.100714","article-title":"Re-evaluating efficacy of vaccines against highly pathogenic avian influenza virus in poultry: a systematic review and meta-analysis","volume":"18","author":"Tseng","year":"2024","journal-title":"One Health"},{"key":"10.1016\/j.vaccine.2026.129121_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetmic.2017.01.002","article-title":"Vaccination against infectious bronchitis virus: a continuous challenge","volume":"206","author":"Jordan","year":"2017","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129121_bb0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41541-025-01191-0","article-title":"Development of a broad-spectrum subunit vaccine against H9N2 avian influenza using HA stem domain scaffold and snoopligase system","volume":"10","author":"Quan","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0200","doi-asserted-by":"crossref","first-page":"11951","DOI":"10.1038\/s41598-018-30356-2","article-title":"A recombinant Newcastle disease virus (NDV) expressing S protein of infectious bronchitis virus (IBV) protects chickens against IBV and NDV","volume":"8","author":"Shirvani","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13567-025-01448-5","article-title":"Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge","volume":"56","author":"Wang","year":"2025","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.129121_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110363","article-title":"Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens","volume":"120","author":"Wu","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129121_bb0215","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/biom11081072","article-title":"Platforms for production of protein-based vaccines: from classical to next-generation strategies","volume":"11","author":"Cid","year":"2021","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129121_bb0220","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00736-5","article-title":"Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2","volume":"8","author":"Leal","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"7830","key":"10.1016\/j.vaccine.2026.129121_bb0230","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41421-021-00320-y","article-title":"RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates","volume":"7","author":"Pan","year":"2021","journal-title":"Cell Discov"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129121_bb0240","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1378\/chest.12-1711","article-title":"Immunobiology of influenza vaccines","volume":"143","author":"Gomez Lorenzo","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129121_bb0245","article-title":"Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes","volume":"14","author":"Chiba","year":"2023","journal-title":"mBio"},{"issue":"Suppl_1","key":"10.1016\/j.vaccine.2026.129121_bb0250","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/infdis\/jiy696","article-title":"Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens","volume":"219","author":"Zost","year":"2019","journal-title":"J Infect Dis"},{"issue":"Suppl_1","key":"10.1016\/j.vaccine.2026.129121_bb0255","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129121_bb0260","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.129121_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02350","article-title":"Mini-HA is superior to full length hemagglutinin immunization in inducing stem-specific antibodies and protection against group 1 influenza virus challenges in mice","volume":"9","author":"van der Lubbe","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129121_bb0270","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0275","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.02608-13","article-title":"Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain","volume":"88","author":"Eggink","year":"2014","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129121_bb0280","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"issue":"5924","key":"10.1016\/j.vaccine.2026.129121_bb0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129121_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-022-00472-2","article-title":"Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice","volume":"7","author":"Grigoryan","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129121_bb0300","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2231573","article-title":"Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD","volume":"12","author":"Li","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129121_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007009","article-title":"Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins","volume":"14","author":"Shang","year":"2018","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129121_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112302","article-title":"A recommended numbering scheme for influenza A HA subtypes","volume":"9","author":"Burke","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129121_bb0315","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00489-23","article-title":"Identification and comparison of the sialic acid-binding domain characteristics of avian coronavirus infectious bronchitis virus spike protein","volume":"97","author":"You","year":"2023","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129121_bb0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12934-024-02534-7","article-title":"The signal peptide of BmNPV GP64 activates the ERAD pathway to regulate heterogeneous secretory protein expression","volume":"23","author":"Liu","year":"2024","journal-title":"Microb Cell Factories"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129121_bb0325","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:40:39Z","timestamp":1793605239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"alternative-id":["S0264410X26009308"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129121","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129121"}}